Trial: 202101211

A Phase III Randomized Trial of Steroids +Tyrosine Kinase Inhibitor Induction with Chemotherapy or Blinatumomab for Newly Diagnosed BCR-ABL-positive Acute Lymphoblastic Leukemia in Adults

Phase

III

Principal Investigator

Uy, Geoffrey

Disease Site

Lymphoid Leukemia

Learn more about this study at: clinicaltrials.gov